Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Emblem Corp EMMBF

"Emblem Corp is a licensed producer of medical cannabis. It is intended to cultivate and cure cannabis for medicinal use. The group operates in the business segment of production and sale of medical cannabis."

OTCPK:EMMBF - Post Discussion

Emblem Corp > Price
View:
Post by Verygood007 on Feb 25, 2019 11:36am

Price

Based on ALEF current price of $2.62 now, the sp of EMC is: $2.62x .8377= $2.19 plus  price of EMC now is $1.80 x premium of 27%=$0.48, which is equal to $2.19+$0.48= $2.67.
Comment by Verygood007 on Feb 25, 2019 11:40am
The closing prices of EMC and ALEF at March 31, 2019 will be used for the calculation purpose. So, my guess it should be around $3.
Comment by highrider2 on Feb 25, 2019 12:44pm
This post has been removed in accordance with Community Policy
Comment by JungleGeorge on Feb 25, 2019 2:53pm
That is correct.  In my calculations without using charting, the price of Aleafia should be near to $3.50/share and that would value the Emblem shares at $2.95/share.  That is the conservative outlook in my opinion.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities